Filter by Doctor (All Doctors) Gordon and GrumleyO'Day Title Physician Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer NCT ID : 03688204 Gordon and Grumley A Phase 1 Study of AGEN1181, an Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Subjects With Advanced Cancer NCT ID : NCT03860272 Protocol Number : C-800-01 Phase : 1 O'Day A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination With Ipilimumab or Nivolumab Monotherapy in Participants With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) NCT ID : NCT03668119 Protocol Number : CA209-848 Phase : 2 O'Day
